| Product Code: ETC13340762 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America mRNA Sequencing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America mRNA Sequencing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America mRNA Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 North America mRNA Sequencing Market - Industry Life Cycle |
3.4 North America mRNA Sequencing Market - Porter's Five Forces |
3.5 North America mRNA Sequencing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America mRNA Sequencing Market Revenues & Volume Share, By Sequencing Type, 2021 & 2031F |
3.7 North America mRNA Sequencing Market Revenues & Volume Share, By Platform, 2021 & 2031F |
3.8 North America mRNA Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 North America mRNA Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 North America mRNA Sequencing Market Revenues & Volume Share, By Data Analysis, 2021 & 2031F |
4 North America mRNA Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America mRNA Sequencing Market Trends |
6 North America mRNA Sequencing Market, 2021 - 2031 |
6.1 North America mRNA Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America mRNA Sequencing Market, Revenues & Volume, By Whole Transcriptome Sequencing, 2021 - 2031 |
6.1.3 North America mRNA Sequencing Market, Revenues & Volume, By Targeted Sequencing, 2021 - 2031 |
6.1.4 North America mRNA Sequencing Market, Revenues & Volume, By Single-Cell Sequencing, 2021 - 2031 |
6.1.5 North America mRNA Sequencing Market, Revenues & Volume, By Small RNA Sequencing, 2020 - 2028 |
6.1.6 North America mRNA Sequencing Market, Revenues & Volume, By Ribosome Profiling, 2020 - 2028 |
6.2 North America mRNA Sequencing Market, Revenues & Volume, By Platform, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America mRNA Sequencing Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.2.3 North America mRNA Sequencing Market, Revenues & Volume, By Single-Cell Sequencing, 2021 - 2031 |
6.2.4 North America mRNA Sequencing Market, Revenues & Volume, By High-Throughput Platforms, 2021 - 2031 |
6.2.5 North America mRNA Sequencing Market, Revenues & Volume, By PCR-Based Methods, 2021 - 2031 |
6.2.6 North America mRNA Sequencing Market, Revenues & Volume, By RNA Microarrays, 2020 - 2028 |
6.3 North America mRNA Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America mRNA Sequencing Market, Revenues & Volume, By Disease Research, 2021 - 2031 |
6.3.3 North America mRNA Sequencing Market, Revenues & Volume, By Cancer Diagnostics, 2021 - 2031 |
6.3.4 North America mRNA Sequencing Market, Revenues & Volume, By Immunology, 2021 - 2031 |
6.3.5 North America mRNA Sequencing Market, Revenues & Volume, By Vaccine Development, 2021 - 2031 |
6.3.6 North America mRNA Sequencing Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.4 North America mRNA Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America mRNA Sequencing Market, Revenues & Volume, By Academic Centers, 2021 - 2031 |
6.4.3 North America mRNA Sequencing Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.4.4 North America mRNA Sequencing Market, Revenues & Volume, By Pharmaceutical Companies, 2020 - 2028 |
6.4.5 North America mRNA Sequencing Market, Revenues & Volume, By Biotechnology Firms, 2020 - 2028 |
6.4.6 North America mRNA Sequencing Market, Revenues & Volume, By Contract Research Organizations, 2020 - 2028 |
6.5 North America mRNA Sequencing Market, Revenues & Volume, By Data Analysis, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America mRNA Sequencing Market, Revenues & Volume, By Bioinformatics Tools, 2020 - 2028 |
6.5.3 North America mRNA Sequencing Market, Revenues & Volume, By Cloud-Based Analysis, 2020 - 2028 |
6.5.4 North America mRNA Sequencing Market, Revenues & Volume, By AI-Based Algorithms, 2020 - 2028 |
6.5.5 North America mRNA Sequencing Market, Revenues & Volume, By Machine Learning Models, 2020 - 2028 |
6.5.6 North America mRNA Sequencing Market, Revenues & Volume, By Genomic Databases, 2020 - 2028 |
7 North America mRNA Sequencing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America mRNA Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
7.2.1 United States (US) mRNA Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
7.2.2 Canada mRNA Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
7.2.3 Rest of North America mRNA Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
7.3 North America mRNA Sequencing Market Revenues & Volume Share, By Platform, 2021 & 2031F |
7.3.1 United States (US) mRNA Sequencing Market, Revenues & Volume, By Platform, 2021 - 2031 |
7.3.2 Canada mRNA Sequencing Market, Revenues & Volume, By Platform, 2021 - 2031 |
7.3.3 Rest of North America mRNA Sequencing Market, Revenues & Volume, By Platform, 2021 - 2031 |
7.4 North America mRNA Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United States (US) mRNA Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Canada mRNA Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Rest of North America mRNA Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America mRNA Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) mRNA Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada mRNA Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America mRNA Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America mRNA Sequencing Market, Revenues & Volume, By Data Analysis, 2021 - 2031 |
7.6.1 United States (US) mRNA Sequencing Market, Revenues & Volume, By Data Analysis, 2021 - 2031 |
7.6.2 Canada mRNA Sequencing Market, Revenues & Volume, By Data Analysis, 2021 - 2031 |
7.6.3 Rest of North America mRNA Sequencing Market, Revenues & Volume, By Data Analysis, 2021 - 2031 |
8 North America mRNA Sequencing Market Key Performance Indicators |
9 North America mRNA Sequencing Market - Export/Import By Countries Assessment |
10 North America mRNA Sequencing Market - Opportunity Assessment |
10.1 North America mRNA Sequencing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America mRNA Sequencing Market Opportunity Assessment, By Sequencing Type, 2021 & 2031F |
10.3 North America mRNA Sequencing Market Opportunity Assessment, By Platform, 2021 & 2031F |
10.4 North America mRNA Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 North America mRNA Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 North America mRNA Sequencing Market Opportunity Assessment, By Data Analysis, 2021 & 2031F |
11 North America mRNA Sequencing Market - Competitive Landscape |
11.1 North America mRNA Sequencing Market Revenue Share, By Companies, 2022 |
11.2 North America mRNA Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here